在肥胖喘中准脂质代谢:前景和治疗机会
Shanshan Wang1, Jianping Zhao1, Jungang Xie1
1Department of Respiratory and Critical Care Medicine, National Clinical Research Center of Respiratory Disease, Key Laboratory of Pulmonary Diseases of Health Ministry, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
International archives of allergy and immunology
|October 20, 2024
概括
肥胖和喘有复杂的联系,脂质代谢异常在严重肥胖喘中起着关键作用. 了解这些脂质通路对于开发这种具有挑战性的疾病的新疗法至关重要.
科学领域:
- 肺部医学 肺部医学
- 代谢学 代谢学 代谢学
- 免疫学 免疫学 免疫学
背景情况:
- 肥胖喘是一种独特的表型,具有严重的症状和不良的治疗反应.
- 有助因素包括环境相互作用,机械压力,炎症和代谢障碍.
- 异常的脂质代谢在肥胖喘中越来越多地被识别出来.
研究的目的:
- 审查了解肥胖喘病因中的生物活性脂质的最新进展.
- 描述参与肥胖喘中脂质代谢的效应细胞和途径.
- 总结目前的基于脂质的疗法及其对肥胖喘的未来潜力.
主要方法:
- 关于代谢学研究的文献综述.
- 分析生物活性脂质在喘中的作用.
- 对效应细胞对脂质代谢物反应的检查.
主要成果:
- 在肥胖的喘患者中显著的脂质代谢异常是显而易见的.
- 特定的生物活性脂质信使与肥胖喘的发展有关.
- 已经确定了关键效应细胞及其脂质反应通路.
结论:
- 不正常的脂质代谢显著影响肥胖喘的发展.
- 需要进一步的研究来澄清脂质,肥胖和喘之间的复杂相互作用.
- 准脂质通路为肥胖喘提供了潜在的治疗策略.
相关概念视频
Antiasthma Drugs: Leukotriene Modifiers
246
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
246
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
240
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
240
Overview of Lipid Metabolism
1.1K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.1K
COPD: Management Using Bronchodilators and Corticosteroids
182
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
182
Drugs Used in Lower Respiratory Disorders: Overview
353
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
353
Asthma: Pathogenesis and Management
361
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
361


